1/29
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
1. Q: What is a pedigree?
A: A diagram showing inheritance of a trait or disease across generations.
2. Q: What is a proband?
A: The first person identified with a disorder who prompts investigation of the family.
3. Q: What do pedigree symbols represent?
A: □ Male; ○ female; shaded = affected; diagonal line = deceased; arrow = proband.
4. Q: What do Roman and Arabic numerals represent in pedigrees?
A: Roman numerals = generations; Arabic numerals = individuals within each generation.
5. Q: What are the key features of autosomal recessive inheritance?
A: Both sexes affected equally; may skip generations; parents of affected individuals are often unaffected carriers.
6. Q: If both parents are carriers (Aa × Aa), what is the risk for each child?
A: 25% affected (aa), 50% carrier (Aa), 25% unaffected non-carrier (AA).
7. Q: What causes cystic fibrosis?
A: Pathogenic variants in CFTR; autosomal recessive inheritance.
8. Q: What causes sickle cell disease, and what is its inheritance?
A: A point mutation in HBB produces hemoglobin S (HbS); disease is typically autosomal recessive. HbA and HbS are codominantly expressed in carriers.
9. Q: Why can the sickle cell allele provide an evolutionary advantage?
A: Heterozygous carriers have some protection against severe Plasmodium falciparum malaria.
10. Q: What are the key features of autosomal dominant inheritance?
A: Both sexes affected equally; often appears in successive generations; an affected heterozygous parent has a 50% risk of passing it to each child.
11. Q: What causes Marfan syndrome?
A: An autosomal dominant FBN1 variant affecting connective tissue, especially skeletal, ocular, and cardiovascular systems.
12. Q: What do penetrance and variable expressivity mean?
A: Penetrance = proportion of people with a genotype who express its phenotype. Variable expressivity = differences in severity or features among affected individuals.
13. Q: What causes achondroplasia?
A: An activating FGFR3 variant impairs growth-plate cartilage development; autosomal dominant, often due to a new mutation.
14. Q: What is the recurrence risk when a parent has Marfan syndrome or achondroplasia?
A: If the parent is heterozygous, 50% per pregnancy. Two pathogenic FGFR3 copies in achondroplasia usually cause a lethal condition.
15. Q: What is a de novo mutation?
A: A new genetic variant that arises rather than being inherited from an affected parent.
16. Q: Why are X-linked recessive disorders more common in males?
A: Males have only one X chromosome, so one pathogenic variant can cause disease.
17. Q: What are the main X-linked recessive disorders, their genes, and symptoms?
A:
Hemophilia A — F8: factor VIII deficiency, prolonged bleeding, easy bruising, joint bleeds.
Duchenne muscular dystrophy — DMD: progressive muscle weakness and degeneration.
Red-green color blindness — OPN1LW, OPN1MW: difficulty distinguishing red and green.
G6PD deficiency — G6PD: hemolytic anemia, jaundice, fatigue.
Hunter syndrome — IDS: developmental delay and organ enlargement.
Fabry disease — GLA: pain, kidney disease, and heart disease.
18. Q: If a mother is a carrier of an X-linked recessive disorder and the father is unaffected, what are the risks?
A: Each son has a 50% risk of being affected; each daughter has a 50% risk of being a carrier.
19. Q: Can an affected father pass an X-linked disorder to his son?
A: No. Fathers pass their Y chromosome to sons and their X chromosome to daughters.
20. Q: What is hemophilia A, and how can mutation type affect severity?
A: An X-linked recessive F8 disorder causing factor VIII deficiency. Nonsense and frameshift variants often cause severe disease; missense variants may cause milder disease.
21. Q: What are the key features of X-linked dominant inheritance?
A: One pathogenic X-linked variant can cause disease in either sex; some disorders are more severe in males.
22. Q: What happens when a father has an X-linked dominant disorder?
A: All daughters inherit his affected X chromosome; none of his sons inherit it from him.
23. Q: What are important X-linked dominant disorders, their genes, and prevalence?
A:
Rett syndrome — MECP2: approximately 1 in 10,000–15,000 live female births.
Fragile X syndrome — FMR1: approximately 1 in 4,000 males and 1 in 8,000 females; technically an X-linked disorder caused by a CGG-repeat expansion.
X-linked hypophosphatemia — PHEX: approximately 1 in 20,000 individuals.
Incontinentia pigmenti — IKBKG: approximately 0.7 in 100,000 individuals.
Alport syndrome — COL4A5 (X-linked form): affects the kidneys, hearing, and eyes. COL4A3 and COL4A4 variants can cause autosomal forms; the listed prevalence is approximately 1 in 50,000 newborns.
24. Q: Why can female carriers of X-linked disorders show mosaic patterns of symptoms?
A: Random X-chromosome inactivation creates cell populations expressing different X chromosomes.
25. Q: What is mosaicism, and how can it arise?
A: Two or more genetically distinct cell populations originating from one fertilized egg; caused by postzygotic mutations, nondisjunction, or anaphase lag.
26. Q: What is hypohidrotic ectodermal dysplasia (HED)?
A: A disorder affecting hair, sweat glands, and teeth. It can be X-linked recessive (EDA) or autosomal recessive/dominant (variants in genes such as EDAR, EDARADD, or WNT10A).
30. Q: If an autosomal recessive disease affects 1 in 1,000 people, how do you calculate carrier frequency?
A: \(q^2=0.001\); \(q\approx0.0316\); \(p\approx0.9684\). Carrier frequency \(2pq\approx0.061\), or about 6.1%.
27. Q: What is the Hardy–Weinberg equation?
A: \(p^2+2pq+q^2=1\), with \(p+q=1\).
28. Q: What do \(p\), \(q\), \(p^2\), \(2pq\), and \(q^2\) represent?
A: \(p\) = frequency of allele A; \(q\) = frequency of allele a; \(p^2\) = AA; \(2pq\) = Aa carriers; \(q^2\) = aa.
29. Q: What conditions are required for Hardy–Weinberg equilibrium?
A: A large population, random mating, and no mutation, natural selection, or migration (gene flow).